Hepatitis Monthly

Published by: Kowsar

A Novel FECH Mutation Causes Erythropoietic Protoporphyria with Severe Liver Dysfunction

Fang Xu 1 , Xiaomei Wang 1 , Xiumei Chi 1 , Xiuting He 1 , Yue Qi 1 , Huijuan Peng 1 , Junqi Niu 1 , Yanjun Cai 1 , * and Pujun Gao 1 , **
Authors Information
1 The First Hospital of Jilin University, Changchun, China
Corresponding Authors:
Article information
  • Hepatitis Monthly: November 2018, 18 (11); e80767
  • Published Online: September 26, 2018
  • Article Type: Research Article
  • Received: June 13, 2018
  • Revised: August 8, 2018
  • Accepted: September 14, 2018
  • DOI: 10.5812/hepatmon.80767

To Cite: Xu F , Wang X , Chi X , He X , Qi Y , et al. A Novel FECH Mutation Causes Erythropoietic Protoporphyria with Severe Liver Dysfunction, Hepat Mon. 2018 ; 18(11):e80767. doi: 10.5812/hepatmon.80767.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
5. Discussion
  • 1. Puy H, Gouya L, Deybach JC. Porphyrias. Lancet. 2010;375(9718):924-37. doi: 10.1016/S0140-6736(09)61925-5. [PubMed: 20226990].
  • 2. Bissell DM, Anderson KE, Bonkovsky HL. Porphyria. N Engl J Med. 2017;377(9):862-72. doi: 10.1056/NEJMra1608634. [PubMed: 28854095].
  • 3. Lecha M, Puy H, Deybach JC. Erythropoietic protoporphyria. Orphanet J Rare Dis. 2009;4:19. doi: 10.1186/1750-1172-4-19. [PubMed: 19744342]. [PubMed Central: PMC2747912].
  • 4. Karim Z, Lyoumi S, Nicolas G, Deybach JC, Gouya L, Puy H. Porphyrias: A 2015 update. Clin Res Hepatol Gastroenterol. 2015;39(4):412-25. doi: 10.1016/j.clinre.2015.05.009. [PubMed: 26142871].
  • 5. Todd DJ. Erythropoietic protoporphyria. Br J Dermatol. 1994;131(6):751-66. [PubMed: 7857832].
  • 6. Holme SA, Whatley SD, Roberts AG, Anstey AV, Elder GH, Ead RD, et al. Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritance. J Invest Dermatol. 2009;129(3):599-605. doi: 10.1038/jid.2008.272. [PubMed: 18787536].
  • 7. Schmidt H, Snitker G, Thomsen K, Lintrup J. Erythropoietic protoporphyria. A clinical study based on 29 cases in 14 families. Arch Dermatol. 1974;110(1):58-64. [PubMed: 4420906].
  • 8. Doss MO, Frank M. Hepatobiliary implications and complications in protoporphyria, a 20-year study. Clin Biochem. 1989;22(3):223-9. [PubMed: 2736774].
  • 9. Schneider-Yin X, Gouya L, Meier-Weinand A, Deybach JC, Minder EI. New insights into the pathogenesis of erythropoietic protoporphyria and their impact on patient care. Eur J Pediatr. 2000;159(10):719-25. [PubMed: 11039124].
  • 10. Bloomer J, Bruzzone C, Zhu L, Scarlett Y, Magness S, Brenner D. Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation. J Clin Invest. 1998;102(1):107-14. doi: 10.1172/JCI1347. [PubMed: 9649563]. [PubMed Central: PMC509071].
  • 11. Polson RJ, Lim CK, Rolles K, Calne RY, Williams R. The effect of liver transplantation in a 13-year-old boy with erythropoietic protoporphyria. Transplantation. 1988;46(3):386-9. [PubMed: 3047929].
  • 12. Thunell S, Harper P, Brun A. Porphyrins, porphyrin metabolism and porphyrias. IV. Pathophysiology of erythyropoietic protoporphyria diagnosis, care and monitoring of the patient. Scand J Clin Lab Invest. 2000;60(7):581-604. [PubMed: 11202051].
  • 13. Windon AL, Tondon R, Singh N, Abu-Gazala S, Porter DL, Russell JE, et al. Erythropoietic protoporphyria in an adult with sequential liver and hematopoietic stem cell transplantation: A case report. Am J Transplant. 2018;18(3):745-9. doi: 10.1111/ajt.14581. [PubMed: 29116687].
  • 14. Long ZB, Wang YW, Yang C, Liu G, Du YL, Nie GJ, et al. Identification of FECH gene multiple variations in two Chinese patients with erythropoietic protoporphyria and a review. J Zhejiang Univ Sci B. 2016;17(10):813-20. doi: 10.1631/jzus.B1600085. [PubMed: 27704751]. [PubMed Central: PMC5064175].
  • 15. Gouya L, Deybach JC, Lamoril J, Da Silva V, Beaumont C, Grandchamp B, et al. Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele. Am J Hum Genet. 1996;58(2):292-9. [PubMed: 8571955]. [PubMed Central: PMC1914527].
  • 16. Gouya L, Puy H, Lamoril J, Da Silva V, Grandchamp B, Nordmann Y, et al. Inheritance in erythropoietic protoporphyria: A common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation. Blood. 1999;93(6):2105-10. [PubMed: 10068685].
  • 17. Gouya L, Puy H, Robreau AM, Bourgeois M, Lamoril J, Da Silva V, et al. The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH. Nat Genet. 2002;30(1):27-8. doi: 10.1038/ng809. [PubMed: 11753383].
  • 18. Gouya L, Puy H, Robreau AM, Lyoumi S, Lamoril J, Da Silva V, et al. Modulation of penetrance by the wild-type allele in dominantly inherited erythropoietic protoporphyria and acute hepatic porphyrias. Hum Genet. 2004;114(3):256-62. doi: 10.1007/s00439-003-1059-5. [PubMed: 14669009].
  • 19. Gouya L, Martin-Schmitt C, Robreau AM, Austerlitz F, Da Silva V, Brun P, et al. Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria. Am J Hum Genet. 2006;78(1):2-14. doi: 10.1086/498620. [PubMed: 16385445]. [PubMed Central: PMC1380220].
  • 20. Whatley SD, Mason NG, Khan M, Zamiri M, Badminton MN, Missaoui WN, et al. Autosomal recessive erythropoietic protoporphyria in the United Kingdom: Prevalence and relationship to liver disease. J Med Genet. 2004;41(8). e105. doi: 10.1136/jmg.2003.016121. [PubMed: 15286165]. [PubMed Central: PMC1473220].
  • 21. Cordiali Fei P, Macri A, Trento E, D'Agosto G, Griso D, Biolcati F, et al. Flow cytometric analysis of fluorocytes in patients with erythropoietic porphyria. Eur J Histochem. 1997;41 Suppl 2:9-10. [PubMed: 9859759].
  • 22. Zhou SN, Xiao SX, Peng ZH, Li BX, Li XL, Liu Y, et al. A novel mutation of the FECH gene in a Chinese family with erythropoietic protoporphyria. J Dermatol Sci. 2007;48(2):145-7. doi: 10.1016/j.jdermsci.2007.07.004. [PubMed: 17723290].
  • 23. Kong XF, Ye J, Gao DY, Gong QM, Zhang DH, Lu ZM, et al. Identification of a ferrochelatase mutation in a Chinese family with erythropoietic protoporphyria. J Hepatol. 2008;48(2):375-9. doi: 10.1016/j.jhep.2007.09.013. [PubMed: 18160121].
  • 24. Lau KC, Lam CW, Fong B, Siu TS, Tam S. DNA-based diagnosis of erythropoietic protoporphyria in two families and the frequency of a low-expression FECH allele in a Chinese population. Clin Chim Acta. 2009;400(1-2):132-4. doi: 10.1016/j.cca.2008.09.031. [PubMed: 18976643].
  • 25. Chen FP, Risheg H, Liu Y, Bloomer J. Ferrochelatase gene mutations in erythropoietic protoporphyria: Focus on liver disease. Cell Mol Biol (Noisy-le-grand). 2002;48(1):83-9. [PubMed: 11929052].
  • 26. Cox TM. Erythropoietic protoporphyria. J Inherit Metab Dis. 1997;20(2):258-69. [PubMed: 9211198].
  • 27. Henriksson M, Timonen K, Mustajoki P, Pihlaja H, Tenhunen R, Peltonen L, et al. Four novel mutations in the ferrochelatase gene among erythropoietic protoporphyria patients. J Invest Dermatol. 1996;106(2):346-50. [PubMed: 8601739].
  • 28. Rufenacht UB, Gouya L, Schneider-Yin X, Puy H, Schafer BW, Aquaron R, et al. Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria. Am J Hum Genet. 1998;62(6):1341-52. doi: 10.1086/301870. [PubMed: 9585598]. [PubMed Central: PMC1377149].
  • 29. Wang X, Yang L, Kurtz L, Lichtin A, DeLeo VA, Bloomer J, et al. Haplotype analysis of families with erythropoietic protoporphyria and novel mutations of the ferrochelatase gene. J Invest Dermatol. 1999;113(1):87-92. doi: 10.1046/j.1523-1747.1999.00637.x. [PubMed: 10417624].
  • 30. Saruwatari H, Ueki Y, Yotsumoto S, Shimada T, Fukumaru S, Kanekura T, et al. Genetic analysis of the ferrochelatase gene in eight Japanese patients from seven families with erythropoietic protoporphyria. J Dermatol. 2006;33(9):603-8. doi: 10.1111/j.1346-8138.2006.00140.x. [PubMed: 16958804].
  • 31. Onaga Y, Ido A, Uto H, Hasuike S, Kusumoto K, Moriuchi A, et al. Hypermethylation of the wild-type ferrochelatase allele is closely associated with severe liver complication in a family with erythropoietic protoporphyria. Biochem Biophys Res Commun. 2004;321(4):851-8. doi: 10.1016/j.bbrc.2004.06.178. [PubMed: 15358105].
  • 32. Zhang F, Lu L, Qian X, Pu LY, Li GQ, Wang XH. Liver transplantation for erythropoietic protoporphyria with hepatic failure: A case report. Transplant Proc. 2008;40(5):1774-6. doi: 10.1016/j.transproceed.2008.03.082. [PubMed: 18589193].
  • 33. Ma J, Xiao S, An J, Wang X, Xu Q, Dong Y, et al. A novel splicing mutation and haplotype analysis of the FECH gene in a Chinese family with erythropoietic protoporphyria. J Eur Acad Dermatol Venereol. 2010;24(6):726-9. doi: 10.1111/j.1468-3083.2009.03471.x. [PubMed: 19888946].
  • 34. Xiaoqing LI, Jie SHI, Yamin LAI. protoporphyria with jaundice as the main manifestation: A clinical, pathological, and genetic analysis of 4 cases. J Clin Hepatol. 2017;33(7):1332-5. doi: 10.3969/j.issn.1001-5256.2017.07.026.
  • 35. Ma JH, Xiao SX, An JG, Wang XP, Xu QQ, Dong YY, et al. [Mutation analysis of ferrochelatase gene in a pedigree with erythropoietic protoporphyria]. Chinese J Dermatol. 2010;43(2):85-7. Chinese.
  • 36. Feng L. [A erythropoietic protoporphyria with the main manifestation of liver injury and abdominal pain]. Chinese J Digestion. 2017;2(37). Chinese.
  • 37. Ma J. [The relationship between gene expression and phenotype in rythropoietic protoporphyria]. Chinese J Dermatol. 2013;7(46). Chinese.
  • 38. Wei X, Ju X, Yi X, Zhu Q, Qu N, Liu T, et al. Identification of sequence variants in genetic disease-causing genes using targeted next-generation sequencing. PLoS One. 2011;6(12). e29500. doi: 10.1371/journal.pone.0029500. [PubMed: 22216297]. [PubMed Central: PMC3244462].
  • 39. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754-60. doi: 10.1093/bioinformatics/btp324. [PubMed: 19451168]. [PubMed Central: PMC2705234].
  • 40. Li R, Li Y, Fang X, Yang H, Wang J, Kristiansen K, et al. SNP detection for massively parallel whole-genome resequencing. Genome Res. 2009;19(6):1124-32. doi: 10.1101/gr.088013.108. [PubMed: 19420381]. [PubMed Central: PMC2694485].
  • 41. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25(16):2078-9. doi: 10.1093/bioinformatics/btp352. [PubMed: 19505943]. [PubMed Central: PMC2723002].
  • 42. Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM; Genomes Project Consortium, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68-74. doi: 10.1038/nature15393. [PubMed: 26432245]. [PubMed Central: PMC4750478].
  • 43. Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, et al. The human gene mutation database: Towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet. 2017;136(6):665-77. doi: 10.1007/s00439-017-1779-6. [PubMed: 28349240]. [PubMed Central: PMC5429360].
  • 44. Casanova-Gonzalez MJ, Trapero-Marugan M, Jones EA, Moreno-Otero R. Liver disease and erythropoietic protoporphyria: A concise review. World J Gastroenterol. 2010;16(36):4526-31. [PubMed: 20857522]. [PubMed Central: PMC2945483].
  • 45. Wu CK, Dailey HA, Rose JP, Burden A, Sellers VM, Wang BC. The 2.0 A structure of human ferrochelatase, the terminal enzyme of heme biosynthesis. Nat Struct Biol. 2001;8(2):156-60. doi: 10.1038/84152. [PubMed: 11175906].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments